← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Novarx Corporation
San Diego, CA
$5,611,684
Total funding
2
Grants
Funding over time
peak $828.1K · FY2005–09$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$5,611,684 · 2
By mechanism
R44$5,611,684 · 2
Investigators at Novarx Corporation
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Allogeneic glioma vaccine using TGF-beta knockouts$828,132
R44 · FY2009 · CA
Allogeneic glioma vaccine using TGF-beta knockouts$810,121
R44 · FY2007 · CA
Allogeneic glioma vaccine using TGF-beta knockouts$808,783
R44 · FY2008 · CA
ALLOGENEIC TGF-B ANTISENSE CELL VACCINE FOR LUNG CANCER$683,587
R44 · FY2005 · CA
ALLOGENEIC TGF-B ANTISENSE CELL VACCINE FOR LUNG CANCER$679,196
R44 · FY2004 · CA
ALLOGENEIC TGF-B ANTISENSE CELL VACCINE FOR LUNG CANCER$679,195
R44 · FY2003 · CA
ALLOGENEIC TGF-B ANTISENSE CELL VACCINE FOR LUNG CANCER$658,375
R44 · FY2006 · CA
ALLOGENEIC TGF-B ANTISENSE CELL VACCINE FOR LUNG CANCER$254,400
R44 · FY2002 · CA
Allogeneic glioma vaccine using TGF-beta knockouts$209,895
R44 · FY2004 · CA